RAN BioLinks Canada
For sponsor country operations & study start-up leaders

Canada has the patients and the investigators. Now give sponsors the speed and the data.

Sponsors decide where trials go based on how fast sites respond, how clearly they can see enrollment, and how much they can trust the patient-level data. MAESTRO is built in Canada, with Canadian hospitals, to make every one of those answers immediate.

Show me faster Canadian start-up30-minute walkthrough · no slides, no obligation
Built in Canada, with Canadian hospitalsCanadian data residencyPHIPA · Loi 25 · PIPEDA awareEnglish & Canadian FrenchICH E6(R3) aligned
What sponsors keep telling us

Canadian sites are good. Getting a clear picture of them is slow.

Country and start-up teams don't pass on Canada because of the science. They pass because the information they need to commit a study arrives late, in pieces, and in a different format from every hospital.

01

Start-up runs on email

Feasibility questionnaires, contracts, budgets, ethics submissions and essential documents move through inboxes. Every handoff adds days, and no one can see the whole path to activation.

02

Responsiveness is the deciding factor

When a sponsor asks a question, the answer depends on who is in the office that week. Slow replies get read as slow sites, and the study goes to another country.

03

Enrollment is reported, not visible

Sponsors get a monthly count in a spreadsheet. They can't see screening, screen failures or which site is about to stall until the timeline has already slipped.

04

Patient-level detail is hard to get

Visit status, eligibility, deviations and follow-up sit across hospital systems and paper. Pulling a reliable patient-level picture means chasing the coordinator.

05

Every hospital works differently

Different templates, different review cycles, different contacts. Sponsors running multi-site Canadian studies rebuild the same process at every institution.

06

Tools built for somewhere else

Most trial software is designed around US and EU workflows. Canadian privacy law, provincial requirements, bilingual sites and hospital research structures get bolted on later, if at all.

Now picture the opposite

Canada becomes the country sponsors choose first.

A sponsor asks a question and gets an answer the same day. They open one view and see start-up status, enrollment and patient progress across every Canadian site, without waiting for a report.

Start-up tracked in inboxes and spreadsheets

Every site's path to activation visible, with owners and dates

Answers that depend on who's in the office

Questions, documents and action items tracked to closure

A monthly enrollment count

Live screening and enrollment, with early warnings on stalling sites

Chasing coordinators for patient status

Patient-level visit and follow-up detail in one governed record

Rebuilding the process at every hospital

One shared way of working across Canadian institutions

Why we build with Canadian hospitals

We start inside the hospital and work outward to the sponsor.

Software that speeds up Canadian start-up has to fit how Canadian hospitals, research institutes and research ethics boards actually work. So we design it with them, not for them.

  1. 01

    1. Work alongside research teams

    We sit with coordinators, investigators, research offices and pharmacy to map where start-up time actually goes: contracts, ethics review, document collection and site initiation.

  2. 02

    2. Build to Canadian requirements from the start

    Health Canada, ICH E6(R3), PHIPA, Loi 25 and PIPEDA, bilingual operation for Quebec sites, and Canadian data residency are built into the design, not added later.

  3. 03

    3. Connect sites and sponsors on one data layer

    Sites work in MAESTRO, and sponsors get role-scoped access to the same live record. Status is shared as it happens instead of being re-reported.

  4. 04

    4. Improve with every study

    What we learn on each Canadian study goes back into templates, workflows and the roadmap, so the next start-up is faster than the last.

Inside MAESTRO Clinical Trials

What sponsors need to commit a study to Canada.

CTMS, eTMF, eISF and QMS on one governed data layer, so start-up, enrollment, patient data and documents all come from the same source of truth.

Start-up & site activation tracking

See every Canadian site's path to activation in one place: feasibility, contracts, budgets, ethics, essential documents and site initiation, each with an owner and a due date.

  • Milestone workflows with owners and due dates
  • Automated reminders and escalations
  • Cross-site start-up view for the country team

Live enrollment visibility

Real-time screening and enrollment across every site, with predictive analytics that flag sites trending behind before the delay is locked into the timeline.

  • Cross-site rollups with per-site drill-down
  • Enrollment projections by site and study
  • At-risk site and bottleneck alerts

Patient-level detail, governed

Patient recruitment, enrollment, visits and follow-up captured in one structured record, with access scoped so sponsors see what they need and hospitals keep control of the rest.

  • Patient recruitment and enrollment tracking
  • Visit, deviation and follow-up status
  • Role- and site-scoped access for sponsors and CRAs

Responsiveness built into the workflow

Sponsor questions, monitoring findings and document requests become tracked action items rather than emails, so nothing waits on someone remembering.

  • Action items tracked to closure
  • Site communication log in one record
  • Real-time eTMF ↔ eISF reconciliation

Made for Canadian hospitals

Designed around how Canadian hospitals and research institutes operate, and around the laws that govern their data.

  • Health Canada aware eTMF and QMS
  • PHIPA, Loi 25, PIPEDA and HIA awareness
  • English and Canadian French interface and templates

Data that stays in Canada

Deploy in Canadian cloud regions, or on a dedicated instance where a hospital's data-sovereignty requirements demand it, with an immutable audit trail on every action.

  • Canadian data residency across six cloud providers
  • 21 CFR Part 11 patterns and append-only audit logs
  • GAMP 5-aligned validation packages (IQ / OQ / PQ)
What actually changes

Faster start-up. Clearer data. More studies placed in Canada.

When Canadian sites can show sponsors exactly where they stand, Canada stops being the country that needs extra follow-up.

45%
Faster trial setup
Structured start-up workflows replace the email chase.
Real-time
Enrollment visibility
One live picture across every Canadian site.
1
Source of truth
Start-up, enrollment, patient and document data on one layer.
60%
Less documentation time
AI classification and filing take the manual load off sites.
“We're scientists who ran studies in Canadian clinical and research settings, and we watched good sites lose trials because the information sponsors needed arrived too slowly. We build MAESTRO with Canadian hospitals so that never has to be the reason again.”
The founding team, RAN BioLinks CanadaA technology company started by scientists · Toronto
Questions

Answered.

The full benefit comes when sites work in MAESTRO and sponsors get role-scoped access to the same live record. We can start with a single hospital or a small group of sites on one study and widen from there. A versioned REST API and connectors keep existing systems connected in the meantime.

Access is role- and site-scoped, so sponsors and CRAs see only what the study and the agreements allow. Every action is logged in an append-only audit trail, data is encrypted in transit and at rest, and the platform is designed with PHIPA, Loi 25, PIPEDA and HIA in mind.

Yes. MAESTRO deploys in Canadian regions across AWS, Azure, GCP, Oracle, IBM and DigitalOcean, with dedicated instances available where a hospital's data-sovereignty requirements are strict.

Yes. The interface, document templates and notifications support English and Canadian French, in line with Loi 25 and the language-of-work requirements common at Quebec research sites.

MAESTRO applies predictive analytics to screening and enrollment data to project where each site and the study will land, and flags sites trending behind early. It supports your team's decisions; it doesn't replace them.

Yes, and we want to hear from you. Book a walkthrough and tell us where start-up time goes at your institution. That is how the product gets built.

Make Canada the fast country

See Canadian start-up in one live view.

Book a 30-minute walkthrough. We'll look at how start-up and enrollment are tracked across your Canadian sites today, show you the live view on a setup like yours, and map the fastest path from there. No slides.

  • 30-minute call
  • No slides, no obligation
  • For sponsors, hospitals and research institutes

Book your Canadian start-up walkthrough

Pick a time and tell us about your studies or your institution. We'll confirm within one business day.

Loading calendar…

Weekends unavailable. All times shown in Toronto, Canada · Eastern Time (ET).

2Pick a time

Select a date to see available times.

3Your details

Invite colleagues who should join the walkthrough — they'll be added to the calendar invite.

Booking sends a request — we confirm by email with a calendar invite. See our Privacy Policy.

RAN BioLinks Canada

© 2026 RAN BioLinks Canada. All rights reserved.